Effects of acute and chronic administrations of phencyclidine on the levels of serotonin and 5-hydroxyindoleacetic acid in discrete brain areas of mouse
Tài liệu tham khảo
Chen, 1959, J. Pharmacol. Exp. Ther., 127, 241
Burns, 1976, Clin. Toxicol., 9, 477, 10.3109/15563657608988151
Castellani, 1981, Europ. J. Pharmacol., 73, 143, 10.1016/0014-2999(81)90086-8
Nabeshima, 1982, J. Pharmacol. Meth., 7, 239, 10.1016/0160-5402(82)90040-7
Nabeshima, 1983, Neurosci. Lett., 37, 69, 10.1016/0304-3940(83)90506-2
Nabeshima, 1984, J. Pharm. Dyn., 7, 51, 10.1248/bpb1978.7.51
Sturgeon, 1979, Europ. J. Pharmacol., 59, 169, 10.1016/0014-2999(79)90279-6
Castellani, 1981, Neuropharmacology, 20, 371, 10.1016/0028-3908(81)90011-3
Malave, 1982, Life Sci., 30, 929, 10.1016/0024-3205(82)90621-X
Nabeshima, 1982, Res. Commun. Subst. Abuse, 2, 343
Nabeshima, 1983, Europ. J. Pharmacol., 86, 271, 10.1016/0014-2999(82)90325-9
Nabeshima, 1983, Europ. J. Pharmacol., 91, 455, 10.1016/0014-2999(83)90170-X
Nabeshima, 1983, Europ. J. Pharmacol., 93, 229, 10.1016/0014-2999(83)90142-5
Nabeshima, 1983, Res. Commun. Sbst. Abuse, 4, 273
Nabeshima, 1984, Pharmacol. Biochem. Behav., 21, 401, 10.1016/S0091-3057(84)80102-1
Raja, 1980, Europ. J. Pharmacol., 63, 229, 10.1016/0014-2999(80)90452-5
Tonge, 1969, Life Sci., 8, 805, 10.1016/0024-3205(69)90141-6
Bedard, 1977, Neuropharmacology, 16, 663, 10.1016/0028-3908(77)90117-4
Grahame-Smith, 1971, J. Neurochem., 18, 1053, 10.1111/j.1471-4159.1971.tb12034.x
Jacobs, 1976, Life Sci., 19, 777, 10.1016/0024-3205(76)90303-9
Martin, 1979, Life Sci., 24, 1699, 10.1016/0024-3205(79)90255-8
Nabeshima, 1984, Res. Commun. Sbst. Abuse, 5, 81
Pinchasi, 1978, Psychopharmacology, 56, 27, 10.1007/BF00571404
Pinchasi, 1978, Psychopharmacology, 56, 37, 10.1007/BF00571405
Stillman, 1979, Ann. Intern. Med., 90, 428, 10.7326/0003-4819-90-3-428
Flint, 1980, Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 4, 233, 10.1016/0364-7722(80)90042-9
Ho, 1981, Biochem. Pharmacol., 30, 545, 10.1016/0006-2952(81)90644-4
Nabeshima, 1981, Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 5, 121, 10.1016/0364-7722(81)90060-6
Tonge, 1971, J. Pharm. Pharmacol., 23, 711, 10.1111/j.2042-7158.1971.tb08752.x
Glowinski, 1966, J. Neurochem., 13, 655, 10.1111/j.1471-4159.1966.tb09873.x
Kanner, 1975, Neurosci. Abstr., 1, 366
Fessler, 1979, Life Sci., 24, 1281, 10.1016/0024-3205(79)90147-4
Finnegan, 1976, Pharmacol. Biochem. Behav., 5, 651, 10.1016/0091-3057(76)90307-5
Kanner, 1975, Psychopharmacol. Commun., 1, 393
Murray, 1979, Life Sci., 24, 2217, 10.1016/0024-3205(79)90097-3
Smith, 1977, Biochem. Pharmacol., 26, 1435, 10.1016/0006-2952(77)90370-7
Arora, 1980, Life Sci., 27, 1607, 10.1016/0024-3205(80)90571-8
Peroutka, 1981, Brain Res., 208, 339, 10.1016/0006-8993(81)90562-X
Leysen, 1982, Mol. Pharmacol., 21, 301
Lucki, 1984, J. Pharmacol. Exp. Ther., 228, 133
Martin, 1982, Neuropharmacology, 21, 119, 10.1016/0028-3908(82)90150-2
Cerrito, 1979, Europ. J. Pharmacol., 57, 427, 10.1016/0014-2999(79)90506-5
Carlsson, 1963, Acta Pharmac. Tox., 20, 140, 10.1111/j.1600-0773.1963.tb01730.x
Haigler, 1974, J. Pharmacol. Exp. Ther., 188, 688
Mosko, 1977, Brain Res., 119, 269, 10.1016/0006-8993(77)90311-0